Vol. 74 No. 1 (2022) | Reumatismo

Current Issue

Vol. 74 No. 1 (2022)

3 May 2022

View this Issue

Impact Factor 2023

Vol. 74 No. 1 (2022)

Published: 3 May 2022

Reviews

The preventive and therapeutic role of physical activity in knee osteoarthritis

R. Restuccia, D. Ruggieri, L. Magaudda, R. Talotta

https://doi.org/10.4081/reumatismo.2022.1466

11826

PDF: 4876
- PDF

Original Articles

The prevalence and clinical spectrum of post-Covid syndrome in patients with rheumatic diseases: a single-center experience

S. Batıbay, R. Koçak Ulucaköy, Z. Günendi, F. Göğüş

https://doi.org/10.4081/reumatismo.2022.1481

2301

PDF: 652
- PDF

Case Reports

Musculoskeletal syndrome treated with global postural re-education in double-redo lung transplantation: a case report with an 8-month follow-up

M. Polastri, G.M. Paganelli, G. Dolci, E. Di Ciaccio, I. Prediletto

https://doi.org/10.4081/reumatismo.2022.1386

2392

PDF: 614
- PDF
Erythema nodosum after COVID-19 vaccine

B. Maranini, G. Ciancio, M. Corazza, F. Ruffilli, G. Galoppini, M. Govoni

https://doi.org/10.4081/reumatismo.2022.1475

2598

PDF: 988
- PDF
COVID-19 as potential aggravating factor for the natural course of new onset-dermatomyositis

M.S.M.S. Faria, S.K. Shinjo

https://doi.org/10.4081/reumatismo.2022.1440

2092

PDF: 552
- PDF

Letters to the Editor

Herpes zoster seven days after SARS-CoV-2 vaccination in a patient with ankylosing spondylitis under adalimumab

J. Finsterer

https://doi.org/10.4081/reumatismo.2022.1474

1937

PDF: 486
- PDF
Reply to: “Herpes zoster seven days after SARS-CoV-2 vaccination in a patient with ankylosing spondylitis under adalimumab” by Josef Finsterer

B. Maranini, G. Ciancio, R. Cultrera, M. Govoni

https://doi.org/10.4081/reumatismo.2022.1482

2162

PDF: 563
- PDF

© PAGEPress 2008-2025 • PAGEPress^® is a registered trademark property of PAGEPress srl, Italy • VAT: IT02125780185 • Privacy